| Tag | Content |
|---|
EnhancerAtlas ID | HS108-22952 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr2:102636990-102637940 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr2:102637247-102637266 | TGAACACTAGGGGGCAGCC | + | 6.49 | | ZNF263 | MA0528.1 | chr2:102637545-102637566 | GGAGGAGGGGAGGAAAAGGCG | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_44807 | chr2:102636977-102637643 | NHLF | | SE_45585 | chr2:102634481-102639286 | Osteoblasts | | SE_52672 | chr2:102637135-102637955 | Small_Intestine |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I102020 | chr2 | 102636681 | 102637862 |
|
Enhancer Sequence | GGGGATTTCA GAGAGCTTCA GAGACACGCT AAGTTTAAAT AATTGGTCTA TAAGGGGAAA 60
ATATATTTTT CTCACAGAGC ATCCAGAGAT TCAGTTGCAC CGCATTTTCC CACGGACTGA 120
GGTGTCCTGA TTGTGTTTGT TTTACAGTCC TGTGAGGATT CGTTCATATC AGCTCCTTGC 180
TTCTGGACAG GCCACTGACT CAGGTCTCCT GAGGCTTTCC GTGGACCGGC ACGGTCCTGT 240
CTCTGCGATA CTGTGCATGA ACACTAGGGG GCAGCCGCCC TACATGCCTG TCTGTGTTGT 300
GATCCTCCCA GGATCTCAGT GGCTCTCAAG GGGTGGTCCT GGGCCAGCAG CGCCTCATCA 360
CCTGGGTACT CAACAGACAT GCAAATCTCG GGTCCCGTGG AGACCTACTG ATTGAAACTG 420
GAGTCTGGGG GCTGTCATCT GTGTCTCACA AGCCCCCGGG TGATGCTGGG GACCCTCAAG 480
TCTAAGAAGC ACTGAGATCC TGGAGGCTTC TTTCTCTCCC TGGATGCCCC AGCTCCATAG 540
GGCAGCGCGT GACTTGGAGG AGGGGAGGAA AAGGCGTCTG GCCGTGGTCG AAAAGCCGTC 600
TGCCCCTCAG GCTGTCCTGC CATGCTGTCT AATGTGTACT CATGTCAGGA TTTCAAAATG 660
CTGTTTCGTG GAAGTGAGGA TGATGAGGCC CGTCGTGGAG ACAACTCACA GCCCTCACCC 720
CCCAGGTGTC CTTTTTGCTC ATTTCAGGGG CCTCGTTTCT TTCTTTCTTT TCTTTTCTTT 780
TTTTTTTTTT TTTTGGTTTT TTTTTGAGGC GGAGTCTCGC TCTGCCACCC AGGCTGGAGT 840
GCAATGGCGC GATCTCGGCT CACTGCGACC TCTACCTCCC GGGTTCAAGC GATTATCCTG 900
TCTCAGCCTC CTGAGTAGCT GGGATTACAG GCTTACGCCA CCAAGCCCAG 950
|
